Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

OTC Healthcare in Ireland to 2011

Published by: Datamonitor

Published: Jul. 31, 2008 - 188 Pages


Table of Contents


EXECUTIVE SUMMARY
Summary Market Level - OTC Healthcare
Summary category level - Analgesics
Summary category level - Cough and Cold Preparations
Summary category level - Traditional Medicines
Summary category level - First Aid Kits
Summary category level - Indigestion Preparations
Summary category level - Vitamins and Minerals
Summary category level - Plasters & Bandages
Summary category level - Medicated Skin Products
Summary category level - Other OTC Healthcare Products
Summary category level - Topical OTC Medicines
INTRODUCTION
What is this report about?
How to use this report
Market Definition
MARKET OVERVIEW
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
LEADING COMPANY PROFILES
Pfizer Inc
GlaxoSmithKline Plc
CATEGORY ANALYSIS - ANALGESICS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
CATEGORY ANALYSIS - TRADITIONAL MEDICINES
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
CATEGORY ANALYSIS - FIRST AID KITS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
CATEGORY ANALYSIS - INDIGESTION PREPARATIONS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
CATEGORY ANALYSIS - VITAMINS AND MINERALS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
CATEGORY ANALYSIS - PLASTERS & BANDAGES
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
CATEGORY ANALYSIS - TOPICAL OTC MEDICINES
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
COUNTRY COMPARISON
Value
Market Share
NEW PRODUCT DEVELOPMENT
Product launches over time
Recent product launches
IRELAND SOCIOECONOMIC PROFILE
Country Overview
Key Facts
Political Overview
Ireland Economic Overview
IRELAND MACROECONOMIC PROFILE
Macroeconomic Indicators
RESEARCH METHODOLOGY
Methodology overview
Secondary research
Market modelling
Primary research
Data finalisation
Ongoing research
CHAPTER 20 APPENDIX
Future readings
How to contact experts in your industry
LIST OF FIGURES
Figure 1: Ireland OTC Healthcare value & value forecast, 2001-2011 (€ m, nominal prices)
Figure 2: Ireland OTC Healthcare category growth comparison, by value, 2001-2011
Figure 3: Ireland OTC Healthcare company share, by value, 2005-2006 (%)
Figure 4: Ireland Analgesics value & value forecast, 2001-2011 (€ m, nominal prices)
Figure 5: Ireland Analgesics category growth comparison, by value, 2001-2011
Figure 6: Ireland Analgesics company share, by value, 2005-2006 (%)
Figure 7: Ireland Cough and Cold Preparations value & value forecast, 2001-2011 (€ m, nominal prices)
Figure 8: Ireland Cough and Cold Preparations category growth comparison, by value, 2001-2011
Figure 9: Ireland Cough and Cold Preparations company share, by value, 2005-2006 (%)
Figure 10: Ireland Traditional Medicines value & value forecast, 2001-2011 (€ m, nominal prices)
Figure 11: Ireland Traditional Medicines company share, by value, 2005-2006 (%)
Figure 12: Ireland First Aid Kits value & value forecast, 2001-2011 (€ m, nominal prices)
Figure 13: Ireland First Aid Kits company share, by value, 2005-2006 (%)
Figure 14: Ireland Indigestion Preparations value & value forecast, 2001-2011 (€ m, nominal prices)
Figure 15: Ireland Indigestion Preparations category growth comparison, by value, 2001-2011
Figure 16: Ireland Vitamins and Minerals value & value forecast, 2001-2011 (€ m, nominal prices)
Figure 17: Ireland Vitamins and Minerals company share, by value, 2005-2006 (%)
Figure 18: Ireland Plasters & Bandages value & value forecast, 2001-2011 (€ m, nominal prices)
Figure 19: Ireland Plasters & Bandages category growth comparison, by value, 2001-2011
Figure 20: Ireland Plasters & Bandages company share, by value, 2005-2006 (%)
Figure 21: Ireland Medicated Skin Products value & value forecast, 2001-2011 (€ m, nominal prices)
Figure 22: Ireland Medicated Skin Products category growth comparison, by value, 2001-2011
Figure 23: Ireland Medicated Skin Products company share, by value, 2005-2006 (%)
Figure 24: Ireland Other OTC Healthcare Products value & value forecast, 2001-2011 (€ m, nominal prices)
Figure 25: Ireland Other OTC Healthcare Products category growth comparison, by value, 2001-2011
Figure 26: Ireland Other OTC Healthcare Products company share, by value, 2005-2006 (%)
Figure 27: Ireland Topical OTC Medicines value & value forecast, 2001-2011 (€ m, nominal prices)
Figure 28: Ireland Topical OTC Medicines category growth comparison, by value, 2001-2011
Figure 29: Ireland Topical OTC Medicines company share, by value, 2005-2006 (%)
Figure 30: Global OTC Healthcare market split (value terms, 2006) - Top 5 countries
Figure 31: Global OTC Healthcare market value, 2001 - 2006 (Top 5 countries)
Figure 32: Map of Ireland
Figure 33: Annual data review process
LIST OF TABLES
Table 1: OTC Healthcare category definitions
Table 2: Ireland OTC Healthcare value, 2001-2006 (€ m, nominal prices)
Table 3: Ireland OTC Healthcare value forecast, 2006-2011 (€ m, nominal prices)
Table 4: Ireland OTC Healthcare value, 2001-2006 (US$ m nominal prices)
Table 5: Ireland OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices)
Table 6: Ireland OTC Healthcare brand share, by value, 2005-2006 (%)
Table 7: Ireland OTC Healthcare value, by brand 2005-2006 (€ m nominal prices)
Table 8: Ireland OTC Healthcare company share by value, 2005-2006 (%)
Table 9: Ireland OTC Healthcare value, by company, 2005-2006 (€ m nominal prices)
Table 10: Ireland OTC Healthcare expenditure per capita, 2001-2006 (€, nominal prices)
Table 11: Ireland OTC Healthcare forecast expenditure per capita, 2006-2011 (€, nominal prices)
Table 12: Ireland OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices)
Table 13: Ireland OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 14: Pfizer Inc Key Facts
Table 15: GlaxoSmithKline Plc Key Facts
Table 16: Ireland Analgesics value, 2001-2006 (€ m, nominal prices)
Table 17: Ireland Analgesics value forecast, 2006-2011 (€ m, nominal prices)
Table 18: Ireland Analgesics value, 2001-2006 (US$ m nominal prices)
Table 19: Ireland Analgesics value forecast, 2006-2011 (US$ m nominal prices)
Table 20: Ireland Analgesics brand share, by value, 2005-2006 (%)
Table 21: Ireland Analgesics value, by brand 2005-2006 (€ m nominal prices)
Table 22: Ireland Analgesics company share by value, 2005-2006 (%)
Table 23: Ireland Analgesics value, by company, 2005-2006 (€ m nominal prices)
Table 24: Ireland Analgesics expenditure per capita, 2001-2006 (€, nominal prices)
Table 25: Ireland Analgesics forecast expenditure per capita, 2006-2011 (€, nominal prices)
Table 26: Ireland Analgesics expenditure per capita, 2001-2006 (US$ nominal prices)
Table 27: Ireland Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 28: Ireland Cough and Cold Preparations value, 2001-2006 (€ m, nominal prices)
Table 29: Ireland Cough and Cold Preparations value forecast, 2006-2011 (€ m, nominal prices)
Table 30: Ireland Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices)
Table 31: Ireland Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices)
Table 32: Ireland Cough and Cold Preparations brand share, by value, 2005-2006 (%)
Table 33: Ireland Cough and Cold Preparations value, by brand 2005-2006 (€ m nominal prices)
Table 34: Ireland Cough and Cold Preparations company share by value, 2005-2006 (%)
Table 35: Ireland Cough and Cold Preparations value, by company, 2005-2006 (€ m nominal prices)
Table 36: Ireland Cough and Cold Preparations expenditure per capita, 2001-2006 (€, nominal prices)
Table 37: Ireland Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (€, nominal prices)
Table 38: Ireland Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices)
Table 39: Ireland Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 40: Ireland Traditional Medicines value, 2001-2006 (€ m, nominal prices)
Table 41: Ireland Traditional Medicines value forecast, 2006-2011 (€ m, nominal prices)
Table 42: Ireland Traditional Medicines value, 2001-2006 (US$ m nominal prices)
Table 43: Ireland Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices)
Table 44: Ireland Traditional Medicines brand share, by value, 2005-2006 (%)
Table 45: Ireland Traditional Medicines value, by brand 2005-2006 (€ m nominal prices)
Table 46: Ireland Traditional Medicines company share by value, 2005-2006 (%)
Table 47: Ireland Traditional Medicines value, by company, 2005-2006 (€ m nominal prices)
Table 48: Ireland Traditional Medicines expenditure per capita, 2001-2006 (€, nominal prices)
Table 49: Ireland Traditional Medicines forecast expenditure per capita, 2006-2011 (€, nominal prices)
Table 50: Ireland Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices)
Table 51: Ireland Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 52: Ireland First Aid Kits value, 2001-2006 (€ m, nominal prices)
Table 53: Ireland First Aid Kits value forecast, 2006-2011 (€ m, nominal prices)
Table 54: Ireland First Aid Kits value, 2001-2006 (US$ m nominal prices)
Table 55: Ireland First Aid Kits value forecast, 2006-2011 (US$ m nominal prices)
Table 56: Ireland First Aid Kits brand share, by value, 2005-2006 (%)
Table 57: Ireland First Aid Kits value, by brand 2005-2006 (€ m nominal prices)
Table 58: Ireland First Aid Kits company share by value, 2005-2006 (%)
Table 59: Ireland First Aid Kits value, by company, 2005-2006 (€ m nominal prices)
Table 60: Ireland First Aid Kits expenditure per capita, 2001-2006 (€, nominal prices)
Table 61: Ireland First Aid Kits forecast expenditure per capita, 2006-2011 (€, nominal prices)
Table 62: Ireland First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices)
Table 63: Ireland First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 64: Ireland Indigestion Preparations value, 2001-2006 (€ m, nominal prices)
Table 65: Ireland Indigestion Preparations value forecast, 2006-2011 (€ m, nominal prices)
Table 66: Ireland Indigestion Preparations value, 2001-2006 (US$ m nominal prices)
Table 67: Ireland Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices)
Table 68: Ireland Indigestion Preparations brand share, by value, 2005-2006 (%)
Table 69: Ireland Indigestion Preparations value, by brand 2005-2006 (€ m nominal prices)
Table 70: Ireland Indigestion Preparations company share by value, 2005-2006 (%)
Table 71: Ireland Indigestion Preparations value, by company, 2005-2006 (€ m nominal prices)
Table 72: Ireland Indigestion Preparations expenditure per capita, 2001-2006 (€, nominal prices)
Table 73: Ireland Indigestion Preparations forecast expenditure per capita, 2006-2011 (€, nominal prices)
Table 74: Ireland Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices)
Table 75: Ireland Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 76: Ireland Vitamins and Minerals value, 2001-2006 (€ m, nominal prices)
Table 77: Ireland Vitamins and Minerals value forecast, 2006-2011 (€ m, nominal prices)
Table 78: Ireland Vitamins and Minerals value, 2001-2006 (US$ m nominal prices)
Table 79: Ireland Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices)
Table 80: Ireland Vitamins and Minerals brand share, by value, 2005-2006 (%)
Table 81: Ireland Vitamins and Minerals value, by brand 2005-2006 (€ m nominal prices)
Table 82: Ireland Vitamins and Minerals company share by value, 2005-2006 (%)
Table 83: Ireland Vitamins and Minerals value, by company, 2005-2006 (€ m nominal prices)
Table 84: Ireland Vitamins and Minerals expenditure per capita, 2001-2006 (€, nominal prices)
Table 85: Ireland Vitamins and Minerals forecast expenditure per capita, 2006-2011 (€, nominal prices)
Table 86: Ireland Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices)
Table 87: Ireland Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 88: Ireland Plasters & Bandages value, 2001-2006 (€ m, nominal prices)
Table 89: Ireland Plasters & Bandages value forecast, 2006-2011 (€ m, nominal prices)
Table 90: Ireland Plasters & Bandages value, 2001-2006 (US$ m nominal prices)
Table 91: Ireland Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices)
Table 92: Ireland Plasters & Bandages brand share, by value, 2005-2006 (%)
Table 93: Ireland Plasters & Bandages value, by brand 2005-2006 (€ m nominal prices)
Table 94: Ireland Plasters & Bandages company share by value, 2005-2006 (%)
Table 95: Ireland Plasters & Bandages value, by company, 2005-2006 (€ m nominal prices)
Table 96: Ireland Plasters & Bandages expenditure per capita, 2001-2006 (€, nominal prices)
Table 97: Ireland Plasters & Bandages forecast expenditure per capita, 2006-2011 (€, nominal prices)
Table 98: Ireland Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices)
Table 99: Ireland Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 100: Ireland Medicated Skin Products value, 2001-2006 (€ m, nominal prices)
Table 101: Ireland Medicated Skin Products value forecast, 2006-2011 (€ m, nominal prices)
Table 102: Ireland Medicated Skin Products value, 2001-2006 (US$ m nominal prices)
Table 103: Ireland Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices)
Table 104: Ireland Medicated Skin Products brand share, by value, 2005-2006 (%)
Table 105: Ireland Medicated Skin Products value, by brand 2005-2006 (€ m nominal prices)
Table 106: Ireland Medicated Skin Products company share by value, 2005-2006 (%)
Table 107: Ireland Medicated Skin Products value, by company, 2005-2006 (€ m nominal prices)
Table 108: Ireland Medicated Skin Products expenditure per capita, 2001-2006 (€, nominal prices)
Table 109: Ireland Medicated Skin Products forecast expenditure per capita, 2006-2011 (€, nominal prices)
Table 110: Ireland Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices)
Table 111: Ireland Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 112: Ireland Other OTC Healthcare Products value, 2001-2006 (€ m, nominal prices)
Table 113: Ireland Other OTC Healthcare Products value forecast, 2006-2011 (€ m, nominal prices)
Table 114: Ireland Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices)
Table 115: Ireland Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices)
Table 116: Ireland Other OTC Healthcare Products brand share, by value, 2005-2006 (%)
Table 117: Ireland Other OTC Healthcare Products value, by brand 2005-2006 (€ m nominal prices)
Table 118: Ireland Other OTC Healthcare Products company share by value, 2005-2006 (%)
Table 119: Ireland Other OTC Healthcare Products value, by company, 2005-2006 (€ m nominal prices)
Table 120: Ireland Other OTC Healthcare Products expenditure per capita, 2001-2006 (€ nominal prices)
Table 121: Ireland Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (€, nominal prices)
Table 122: Ireland Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices)
Table 123: Ireland Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 124: Ireland Topical OTC Medicines value, 2001-2006 (€ m, nominal prices)
Table 125: Ireland Topical OTC Medicines value forecast, 2006-2011 (€ m, nominal prices)
Table 126: Ireland Topical OTC Medicines value, 2001-2006 (US$ m nominal prices)
Table 127: Ireland Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices)
Table 128: Ireland Topical OTC Medicines brand share, by value, 2005-2006 (%)
Table 129: Ireland Topical OTC Medicines value, by brand 2005-2006 (€ m nominal prices)
Table 130: Ireland Topical OTC Medicines company share by value, 2005-2006 (%)
Table 131: Ireland Topical OTC Medicines value, by company, 2005-2006 (€ m nominal prices)
Table 132: Ireland Topical OTC Medicines expenditure per capita, 2001-2006 (€, nominal prices)
Table 133: Ireland Topical OTC Medicines forecast expenditure per capita, 2006-2011 (€, nominal prices)
Table 134: Ireland Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices)
Table 135: Ireland Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 136: Global OTC Healthcare market value, 2006
Table 137: Global OTC Healthcare market split (value terms (US$ m), 2006) - Top 5 countries
Table 138: Leading players - Top 5 countries
Table 139: Ireland OTC Healthcare new product launches (reports) and SKUs, by company 2006
Table 140: Ireland OTC Healthcare new product launches (reports), by flavor and fragrances 2006
Table 141: Ireland OTC Healthcare new product launches (reports), by Ingredients 2006
Table 142: Ireland OTC Healthcare new product launches (reports), by Package tags or Claims 2006
Table 143: Ireland OTC Healthcare new product launches (reports)
Table 144: Ireland Key Facts
Table 145: Ireland population, by age group, 2000-2005 (millions)
Table 146: Ireland population forecast, by age group, 2005-2010 (millions)
Table 147: Ireland population, by gender, 2000-2005 (millions)
Table 148: Ireland population forecast, by gender, 2005-2010 (millions)
Table 149: Ireland real GDP, 2000-2005 (€ bn, 2005 prices)
Table 150: Ireland real GDP forecast, 2005-2010 (€ bn, 2005 prices)
Table 151: Ireland nominal GDP, 2000-2005 (€ bn, nominal prices)
Table 152: Ireland real GDP, 2000-2005 (US$ bn, 2005 prices)
Table 153: Ireland real GDP forecast, 2005-2010 (US$ bn, 2005 prices)
Table 154: Ireland consumer price index, 2000-2005 (2000=100)
Table 155: Ireland consumer price index, 2005-2010 (2000=100)
Table 156: Ireland exchange rate, 2000-2005

Abstract

Introduction

This databook is a detailed information resource covering all the key data points on OTC Healthcare in Ireland. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011.

Scope
  • Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
  • Provides market value, volume, expenditure and consumption data by market, segment and subsegment
  • Includes company and brand share data by categories
Highlights

The market for OTC Healthcare in Ireland increased between 2001-2006, growing at an average annual rate of 4.6%.

The leading company in the market in 2006 was Pfizer Inc. The second-largest player was GlaxoSmithKline Plc with Bayer AG in third place.

Reasons to Purchase
  • Discover the major quantitative trends affecting the OTC Healthcare markets
  • Understand consumers' consumption and expenditure patterns
  • Understand the future direction of the market with reliable historical data and full five year forecasting


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options

Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008